Search

Home Media centre Archive releases

• Latest releases
• Regulatory announcements
• Archive releases
  • 2009 releases
  • 2008 releases
  • 2007 releases
  • 2006 releases
  • 2005 releases
  • 2004 releases
  • 2003 releases
• Presentations and webcasts
• Media contacts

2009 releases

Display #  5101520253050100All

#	Article Title	Date
1	Vernalis announces clinical update on partnered compounds AUY922 and HSP990	Monday, 14 December 2009
2	Vernalis Earns Milestone Payment in connection with its 2008 sale of Apokyn and its US commercial operations	Friday, 11 December 2009
3	Interim Management Statement for the period to 12 November 2009	Thursday, 12 November 2009
4	Vernalis initiates Pilot Study of V3381 in patients with chronic cough	Tuesday, 06 October 2009
5	Vernalis completes recruitment in V3381 Phase II IN-STEP study for neuropathic pain	Tuesday, 15 September 2009
6	Vernalis and GlaxoSmithKline enter into a collaboration, option and license agreement over a novel Vernalis oncology programme	Thursday, 06 August 2009
7	Announcement of Interim results for the six months ended 30 June 2009	Thursday, 06 August 2009
8	Vernalis Announces New Oncology Development Candidate	Tuesday, 21 July 2009
9	Vernalis receives milestone payment in Hsp90 inhibitor collaboration	Thursday, 16 July 2009
10	Notice of 2009 Half Year Results	Wednesday, 08 July 2009

Page 1 of 2

• Start
• Prev
• 1
• 2
• Next
• End